CompletedPhase 3NCT00002517
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Catherine Behar, MD, MDHopital Americain
- Intervention
- cytarabine(drug)
- Eligibility
- 14 years · All sexes
- Timeline
- 1993
Study locations (23)
- Algemeen Ziekenhuis Middelheim, Antwerp, Belgium
- Hopital Universitaire Des Enfants Reine Fabiola, Brussels, Belgium
- Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels, Belgium
- Universitair Ziekenhuis Gent, Ghent, Belgium
- U.Z. Gasthuisberg, Leuven, Belgium
- Centre Hospitalier Regional de la Citadelle, Liège, Belgium
- Clinique de l'Esperance, Montegnée, Belgium
- Centre Hospitalier Regional et Universitaire d'Angers, Angers, France
- CHR de Besancon - Hopital Saint-Jacques, Besançon, France
- CHU de Caen, Caen, France
- CHR de Grenoble - La Tronche, Grenoble, France
- Centre Hospitalier Regional de Lille, Lille, France
- Hopital Debrousse, Lyon, France
- Hopital Arnaud de Villeneuve, Montpellier, France
- CHR Hotel Dieu, Nantes, France
- +8 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00002517 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.